drugset / Trial / NCT05492201
A Study of LY3873862 in Healthy Participants
RandomizedParallel-groupDouble-blindBasic science
Summary
The main purpose of this study is to evaluate the safety and tolerability of LY3873862 when administered either in single or multiple doses in healthy participants. The study will also assess how fast LY3873862 gets into the blood stream and how long it takes the body to remove it. The study is open to healthy participants. The study will last up to approximately 58, 72, and 72 days for Part A, B, and C, respectively.
Timeline
- Start
- 2022-08-11
- Primary completion
- 2025-04-29
- Completion
- 2025-04-29
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | LY3873862 | Unknown | — | Oral |
Indications
No indication recorded.